by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
by David Kent | Nov 17, 2011
While many researchers will feel disheartened by last month’s ruling in the Court of Justice of the European Union that prohibits scientific research patents on human embryonic stem cell products (see Ubaka Ogbogu’s article), it seems some positive news is emerging...
by Paul Krzyzanowski | Oct 27, 2011
Canada was built upon the inventiveness and resourcefulness of people who lived here. Why then, have Canadians long heard and read about being second best, sellouts, and in general not that great? Thinking we aren’t competitive has almost become a national mantra. But...
by Paul Krzyzanowski | Jun 30, 2011
Success in a research career is solely defined by ones ability to churn out great academic papers, right? Don’t be so sure. It’s true that successful research careers can be launched with a Science or Nature paper, but many skills other than purely academic ones are...
by Paul Krzyzanowski | Mar 9, 2011
Patenting report shows disconnect in Canada by Paul Krzyzanowski Got a patentable idea? You might want to move to Switzerland. A recent article in the Globe and Mail compared Canada’s patenting activity to other major countries, and the small European nation...
by Stem Cell Network | Jan 12, 2011
In an article in the Globe and Mail this past weekend, reporter Carolyn Abraham provided an interesting and under-reported glimpse into the cosmetics industry use of stem cells to market their products. She notes: “In science, ‘stem cell’ has been...
Comments